Literature DB >> 14002130

Thyroxine degradation. II. Products of thyroxine degradation by rat liver microsomes.

J WYNN, R GIBBS.   

Abstract

Entities:  

Keywords:  LIVER; THYROXIN

Mesh：

Substances：

Year:  1962        PMID： 14002130

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  7 in total

1.  Formation of iodoprotein during the peripheral metabolism of 3,5,3'-triiodo-L-thyronine-125I in the euthyroid man and rat.

Authors:  M I Surks; J H Oppenheimer
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

2.  Formation of diiodotyrosine from thyroxine. Ether-link cleavage, an alternate pathway of thyroxine metabolism.

Authors:  A Balsam; F Sexton; M Borges; S H Ingbar
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

3.  Tissue iodoprotein formation during the peripheral metabolism of the thyroid hormones.

Authors:  M I Surks; H L Schwartz; J H Oppenheimer
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

4.  Ether link cleavage is the major pathway of iodothyronine metabolism in the phagocytosing human leukocyte and also occurs in vivo in the rat.

Authors:  A G Burger; D Engler; U Buergi; M Weissel; G Steiger; S H Ingbar; R E Rosin; B M Babior
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

5.  The integrity of the ether linkage during thyroxine metabolism in man.

Authors:  C S Pittman; V H Read; J B Chambers; H Nakafuji
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

6.  Urinary metabolites of 14 C-labeled thyroxine in man.

Authors:  C S Pittman; M W Buck; J B Chambers
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

7.  Slow fractional removal of nonextractable iodine from rat tissue after injection of labeled L-thyroxine and 3,5,3'-triiodo-L-thyronine. A possible clue to the mechanism of initiation and persistence of hormonal action.

Authors:  J H Oppenheimer; M I Surks; H L Schwartz
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.